Fumio Takei

10.3k total citations · 2 hit papers
157 papers, 8.6k citations indexed

About

Fumio Takei is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy. According to data from OpenAlex, Fumio Takei has authored 157 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Immunology, 39 papers in Radiology, Nuclear Medicine and Imaging and 32 papers in Immunology and Allergy. Recurrent topics in Fumio Takei's work include Immune Cell Function and Interaction (78 papers), T-cell and B-cell Immunology (57 papers) and Monoclonal and Polyclonal Antibodies Research (38 papers). Fumio Takei is often cited by papers focused on Immune Cell Function and Interaction (78 papers), T-cell and B-cell Immunology (57 papers) and Monoclonal and Polyclonal Antibodies Research (38 papers). Fumio Takei collaborates with scholars based in Canada, United States and United Kingdom. Fumio Takei's co-authors include Timotheus Y.F. Halim, Dixie L. Mager, Itziar Martínez-González, Catherine A. Steer, Laura Mathä, Kelly M. McNagny, Matthew J. Gold, Ann Sun, Ramona Krauss and Jack Brennan and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Fumio Takei

157 papers receiving 8.5k citations

Hit Papers

Group 2 Innate Lymphoid Cells Are Critical for the Initia... 2012 2026 2016 2021 2014 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumio Takei Canada 50 6.6k 2.0k 1.4k 1.3k 1.1k 157 8.6k
José-Carlos Gutierrez-Ramos United States 41 5.1k 0.8× 914 0.5× 1.5k 1.1× 1.2k 0.9× 1.8k 1.6× 60 8.1k
Marika Sarfati Canada 51 4.9k 0.7× 564 0.3× 1.5k 1.1× 1.1k 0.9× 1.5k 1.4× 128 7.5k
Guttorm Haraldsen Norway 39 4.4k 0.7× 1.3k 0.6× 1.6k 1.1× 778 0.6× 626 0.6× 89 7.2k
José Carlos Gutierrez‐Ramos United States 34 4.5k 0.7× 718 0.4× 1.6k 1.1× 1.3k 1.0× 1.4k 1.3× 55 7.9k
Clemens A. Dahinden Switzerland 46 4.3k 0.7× 649 0.3× 1.1k 0.8× 2.1k 1.6× 2.6k 2.3× 98 7.6k
Sandra Zurawski United States 31 6.6k 1.0× 579 0.3× 1.2k 0.9× 1.3k 1.0× 1.8k 1.6× 52 9.3k
Shixin Qin United States 37 6.4k 1.0× 628 0.3× 1.2k 0.8× 721 0.5× 921 0.8× 49 9.1k
Lynne A. Lapierre United States 35 2.0k 0.3× 980 0.5× 2.3k 1.7× 1.2k 0.9× 619 0.6× 65 6.4k
Richard A. Kroczek Germany 54 9.2k 1.4× 677 0.3× 2.1k 1.5× 979 0.7× 635 0.6× 103 12.5k
Jane H. Buckner United States 55 7.2k 1.1× 1.4k 0.7× 2.0k 1.4× 392 0.3× 438 0.4× 188 11.8k

Countries citing papers authored by Fumio Takei

Since Specialization
Citations

This map shows the geographic impact of Fumio Takei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Takei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Takei more than expected).

Fields of papers citing papers by Fumio Takei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Takei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Takei. The network helps show where Fumio Takei may publish in the future.

Co-authorship network of co-authors of Fumio Takei

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Takei. A scholar is included among the top collaborators of Fumio Takei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Takei. Fumio Takei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sadeghalvad, Mona, et al.. (2023). Flow cytometric analysis of innate lymphoid cells: challenges and solutions. Frontiers in Immunology. 14. 1198310–1198310. 9 indexed citations
2.
Martínez-González, Itziar, Laura Mathä, Catherine A. Steer, et al.. (2016). Allergen-Experienced Group 2 Innate Lymphoid Cells Acquire Memory-like Properties and Enhance Allergic Lung Inflammation. Immunity. 45(1). 198–208. 242 indexed citations
3.
Kastrukoff, Lorne F., Allen S. Lau, Fumio Takei, et al.. (2010). Redundancy in the immune system restricts the spread of HSV-1 in the central nervous system (CNS) of C57BL/6 mice. Virology. 400(2). 248–258. 30 indexed citations
4.
Mace, Emily M., Susan J. Monkley, David R. Critchley, & Fumio Takei. (2009). A Dual Role for Talin in NK Cell Cytotoxicity: Activation of LFA-1-Mediated Cell Adhesion and Polarization of NK Cells. The Journal of Immunology. 182(2). 948–956. 54 indexed citations
5.
Takei, Fumio, et al.. (2009). An Accessory Role for B Cells in the IL-12-Induced Activation of Resting Mouse NK Cells. The Journal of Immunology. 183(6). 3608–3615. 8 indexed citations
6.
Takei, Fumio, et al.. (2009). NK cell development from a novel progenitor found in the murine lung (138.10). The Journal of Immunology. 182(Supplement_1). 138.10–138.10. 3 indexed citations
7.
Rogers, Sally, A. MAUREEN ROUHI, Fumio Takei, & Dixie L. Mager. (2006). A Role for DNA Hypomethylation and Histone Acetylation in Maintaining Allele-Specific Expression of Mouse NKG2A in Developing and Mature NK Cells. The Journal of Immunology. 177(1). 414–421. 15 indexed citations
8.
ROUHI, A. MAUREEN, Liane Gagnier, Fumio Takei, & Dixie L. Mager. (2006). Evidence for Epigenetic Maintenance of Ly49a Monoallelic Gene Expression. The Journal of Immunology. 176(5). 2991–2999. 35 indexed citations
9.
Parachoniak, Christine A., et al.. (2005). Expression of rearranged TCRγ genes in natural killer cells suggests a minor thymus-dependent pathway of lineage commitment. Blood. 107(7). 2673–2679. 45 indexed citations
10.
Takei, Fumio, et al.. (2005). Development of prototype micro fuel cells for mobile electronics. 41(2). 191–200. 8 indexed citations
11.
Maeda, Motoi, Carmine Carpenito, Ryan C. Russell, et al.. (2005). Murine CD160, Ig-Like Receptor on NK Cells and NKT Cells, Recognizes Classical and Nonclassical MHC Class I and Regulates NK Cell Activation. The Journal of Immunology. 175(7). 4426–4432. 67 indexed citations
12.
Maeda, Motoi, et al.. (2004). CD1d-Independent NKT Cells in β2-Microglobulin-Deficient Mice Have Hybrid Phenotype and Function of NK and T Cells. The Journal of Immunology. 172(10). 6115–6122. 30 indexed citations
13.
Maeda, Motoi, Naoyuki Uchida, Connie J. Eaves, & Fumio Takei. (2003). Slow receptor acquisition by NK cells regenerated in vivo from transplanted fetal liver or adult bone marrow stem cells. Experimental Hematology. 31(11). 1015–1018. 6 indexed citations
14.
Wilhelm, Brian T., Josette‐Renée Landry, Fumio Takei, & Dixie L. Mager. (2003). Transcriptional Control of Murine CD94 Gene: Differential Usage of Dual Promoters by Lymphoid Cell Types. The Journal of Immunology. 171(8). 4219–4226. 19 indexed citations
15.
Maeda, Motoi, et al.. (2003). Slow receptor acquisition by NK cells regenerated in vivo from transplanted fetal liver or adult bone marrow stem cells. Experimental Hematology. 31(11). 1015–1018. 5 indexed citations
16.
Maeda, Motoi, Stefan Lohwasser, Marc Delcommenne, et al.. (2002). Orderly and Nonstochastic Acquisition of CD94/NKG2 Receptors by Developing NK Cells Derived from Embryonic Stem Cells In Vitro. The Journal of Immunology. 168(10). 4980–4987. 35 indexed citations
17.
Maeda, Motoi, Stefan Lohwasser, Takashi Yamamura, & Fumio Takei. (2001). Regulation of NKT Cells by Ly49: Analysis of Primary NKT Cells and Generation of NKT Cell Line. The Journal of Immunology. 167(8). 4180–4186. 51 indexed citations
18.
Ohh, Michael & Fumio Takei. (1996). New insights into the regulation of ICAM-1 gene expression. Leukemia & lymphoma. 20(3-4). 223–228. 21 indexed citations
19.
Howard, D., Allen Eaves, & Fumio Takei. (1986). Monoclonal antibodies specific for human b lymphoma cells. Laboratory Investigation. 54(1). 27. 1 indexed citations
20.
Smedley, Howard, P J Finan, E. S. Lennox, et al.. (1983). Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody. British Journal of Cancer. 47(2). 253–259. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026